Navio
Todd Meyerrose is the current CEO at Navio. Prior to this, they were the CEO at Osmind, RxLive, and ixlayer. Todd has also held positions at Genome Medical, Inc., Lexent Bio, Mend Bio, and KF Business Ventures. Todd Meyerrose received their undergraduate degree from Stanford University.
Todd Meyerrose earned their PhD in Molecular Cell Biology from Washington University School of Medicine in St. Louis and their PhD in Craniofacial Biology and Development from the University of Southern California. Todd also holds a BS in Biology from the University of Kentucky.
Navio
1 followers
Navio is changing the narrative around cancer. Healthcare providers - get early access to treatment timelines that can save you time and improve patient experience. Patients - get Navio’s free app for patients and caregivers to manage treatment for malignant brain tumors.